Hot Pursuit     12-Apr-21
Solara Active Pharma Sciences Ltd leads gainers in 'A' group
Suven Life Sciences Ltd, Cipla Ltd, Divis Laboratories Ltd and Ipca Laboratories Ltd are among the other gainers in the BSE's 'A' group today, 12 April 2021.

Suven Life Sciences Ltd, Cipla Ltd, Divis Laboratories Ltd and Ipca Laboratories Ltd are among the other gainers in the BSE's 'A' group today, 12 April 2021.

Solara Active Pharma Sciences Ltd soared 8.38% to Rs 1485.7 at 11:49 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 37497 shares were traded on the counter so far as against the average daily volumes of 6210 shares in the past one month.

Suven Life Sciences Ltd surged 5.32% to Rs 86.15. The stock was the second biggest gainer in 'A' group. On the BSE, 3.26 lakh shares were traded on the counter so far as against the average daily volumes of 57585 shares in the past one month.

Cipla Ltd spiked 5.19% to Rs 928.05. The stock was the third biggest gainer in 'A' group. On the BSE, 8.03 lakh shares were traded on the counter so far as against the average daily volumes of 1.63 lakh shares in the past one month.

Divis Laboratories Ltd spurt 3.83% to Rs 3895. The stock was the fourth biggest gainer in 'A' group. On the BSE, 34302 shares were traded on the counter so far as against the average daily volumes of 30285 shares in the past one month.

Ipca Laboratories Ltd jumped 3.76% to Rs 2163.6. The stock was the fifth biggest gainer in 'A' group. On the BSE, 22964 shares were traded on the counter so far as against the average daily volumes of 16127 shares in the past one month.

Previous News
  Cipla allots 35,106 equity shares under ESOP
 ( Corporate News - 05-Jul-24   11:02 )
  Cipla to conduct board meeting
 ( Corporate News - 05-Jul-24   10:23 )
  Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
 ( Corporate News - 28-Jun-24   19:23 )
  Solara Active Pharma Sciences grants 95,200 stock options
 ( Corporate News - 28-Jun-24   12:46 )
  Cipla Ltd eases for fifth straight session
 ( Hot Pursuit - 25-Jun-24   13:35 )
  USFDA classifies inspection of Cipla's Patalganga unit as 'Voluntary Action Indicated'
 ( Corporate News - 25-Jun-24   12:12 )
  Cipla gets VAI classification from USFDA for Patalganga facility
 ( Hot Pursuit - 25-Jun-24   11:34 )
  Cipla slides as Goa facility gets 6 USFDA observations
 ( Hot Pursuit - 24-Jun-24   09:47 )
  Cipla Goa facility gets 6 USFDA observations
 ( Hot Pursuit - 22-Jun-24   16:22 )
  Cipla's Goa unit completes USFDA inspection
 ( Corporate News - 22-Jun-24   11:47 )
  Cipla to invest additional EUR 3 million in Ethris GmbH
 ( Corporate News - 18-Jun-24   17:19 )
Other Stories
  PEL board OKs ad hoc appointments post Rupen Patel's passing
  06-Jul-24   16:41
  Info Edge Q1 FY25 billings climb 11% YoY
  06-Jul-24   15:50
  IndusInd Bank advances climb 16% YoY in Q1 FY25
  06-Jul-24   15:18
  Adani Wilmar reports 13% volume growth in Q1 FY25
  06-Jul-24   14:44
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
Back Top